Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise

As Sanofi reports Consumer Healthcare second-quarter sales up by 9%, the company is hopeful it can progress its plan to switch erectile dysfunction drug Cialis in the US following a constructive meeting with the FDA.

Sanofi_France
• Source: Shutterstock

Sanofi has had a “positive and constructive” meeting with the US Food and Drug Administration to get its switch of erection dysfunction drug Cialis back on track.

More from Rx-to-OTC Switch

More from Health